Table: Hisamitsu -Q1 group results

Hisamitsu Pharmaceutical Co

09/07/2020 07:00

Jul 9 (Reuters)- 
             Hisamitsu Pharmaceutical Co Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  May 31, 2020        May 31, 2019     Feb 28, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               24.88               29.23           127.00    
                   (-14.9 pct)         (-12.8 pct)      (-9.9 pct)  
  Operating            1.08                2.78            12.90    
                   (-61.2 pct)         (-36.3 pct)      (-43.2 pct) 
  Recurring          418 mln               2.86            14.80    
                   (-85.4 pct)         (-35.6 pct)      (-42.3 pct) 
  Net                113 mln               1.91            10.60    
                   (-94.1 pct)         (-44.6 pct)      (-43.3 pct) 
  EPS               1.39 yen            23.15 yen       129.80 yen  
  EPS Diluted       1.39 yen            23.13 yen                   
  Ann Div                               83.00 yen        83.50 yen  
  -Q2 div                               41.50 yen        41.75 yen  
  -Q4 div                               41.50 yen        41.75 yen  
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T